Opportunities and barriers in biosimilar market

Biopharmaceutical drugs (or biologics) have outperformed the pharmaceutical market as a whole largely due to two factors: they address areas of clinical need that are unmanageable with conventional therapeutics and they are able to command a premium price.

However, experts say the process to develop a biosimilar – essentially generic version of biopharmaceuticals – is more complex than that ...